Recently, a study suggested that the increased expression of TREM-1 in tissue biopsies and circulating neutrophil and monocytes may precede changes in serum levels of other inflammatory markers in individuals with diabetes and with TREM-1 presenting a possible role in the underlying pathophysiology of obesity and associated comorbidities [15]. This evidence concerns the gene TREM1 and diabetes mellitus.